Clinical Trials Sponsored by Innovative Medicines Initiative (IMI) COMBACTE-CARE
Total 7 results
-
PfizerInnovative Medicines Initiative (IMI) COMBACTE-CARECompletedComplicated Intra-Abdominal Infections, cIAIsSpain, France, Germany
-
PfizerBiomedical Advanced Research and Development Authority; Innovative Medicines...CompletedVentilator Associated Pneumonia | Complicated Intra-abdominal Infection | Hosptial Acquired PneumoniaSpain, China, Korea, Republic of, Philippines, United States, Romania, Taiwan, Italy, Malaysia, Mexico, India, Israel, Turkey, Greece, Thailand, Czechia, Croatia, Argentina, Russian Federation, Bulgaria, Ukraine
-
Mira ZuidgeestSanofi; Innovative Medicines Initiative; IMI Trials@Home consortiumRecruitingDiabetes Mellitus, Type 2United Kingdom, Denmark, Germany
-
MedImmune LLCNational Institute of Allergy and Infectious Diseases (NIAID); Innovative Medicines... and other collaboratorsCompletedStaphylococcus Aureus PneumoniaSpain, Belgium, United States, France, Germany, Czechia, Greece, Switzerland, Hungary, Portugal
-
MedImmune LLCNational Institute of Allergy and Infectious Diseases (NIAID); Antibacterial... and other collaboratorsCompletedPseudomonas AeruginosaSpain, United States, Belgium, France, Hungary, United Kingdom, Israel, Austria, Portugal, Greece, Czechia, Turkey, Croatia, Ireland
-
Frank G. HolzRadboud University Medical Center; Bayer; Hoffmann-La Roche; Novartis Pharmaceuticals and other collaboratorsActive, not recruitingAge Related Macular Degeneration (AMD)Germany, Italy, Netherlands, United Kingdom, France, Portugal, Denmark
-
King's College LondonMedical University of Graz; Radboud University Medical Center; Novo Nordisk A/S; Juvenile Diabetes Research Foundation and other collaboratorsCompletedDiabetes Mellitus, Type 2 | Hypoglycemia | Diabetes Mellitus, Type 1 | Hypoglycemia UnawarenessUnited Kingdom